Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
US9526705B2 · kind B2 · utility
3Cited by
49References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2016 |
| Grant date | Dec 27, 2016 |
| Priority date | — |
| Expiry date | Jan 7, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Lipidated glycosaminoglycan particles, prepared by reacting a glycosaminoglycan with at least one lipid to cross-link the carboxylic acid groups in the glycosaminoglycan with a primary amine in the lipid, are used to encapsulate drugs for use in the treatment of pathological conditions in an animal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.